Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part II: targeting cell cycle events, caspases, NF-κB and the proteasome

作者: Donavon C Hiss , Gary A Gabriels

DOI: 10.1517/17460440903055032

关键词:

摘要: Background: Endoplasmic reticulum stress (ERS), the unfolded protein response (UPR) and apoptosis signal transduction pathways are fundamental to normal cellular homeostasis survival, but e...

参考文章(194)
Ivana Zavrski, Christian Jakob, Martin Kaiser, Claudia Fleissner, Ulrike Heider, Orhan Sezer, Molecular and Clinical Aspects of Proteasome Inhibition in the Treatment of Cancer Targeted Therapies in Cancer. ,vol. 176, pp. 165- 176 ,(2007) , 10.1007/978-3-540-46091-6_14
Ismail Can, Satoko Tahara-Hanaoka, Kaori Hitomi, Takako Nakano, Chigusa Nakahashi-Oda, Naoki Kurita, Shin-ichiro Honda, Kazuko Shibuya, Akira Shibuya, Caspase-Independent Cell Death by CD300LF (MAIR-V), an Inhibitory Immunoglobulin-Like Receptor on Myeloid Cells The Journal of Immunology. ,vol. 180, pp. 207- 213 ,(2008) , 10.4049/JIMMUNOL.180.1.207
Yat-Pang Chau, Hsiu-Ni Kung, Chung-Jiuan Jeng, Kuo-Shyan Lu, Yi-Chen Lien, Involvement of endoplasmic reticulum stress and activation of MAP kinases in beta-lapachone-induced human prostate cancer cell apoptosis. Histology and Histopathology. ,vol. 23, pp. 1299- 1308 ,(2008) , 10.14670/HH-23.1299
Grzegorz Nalepa, Mark Rolfe, J. Wade Harper, Drug discovery in the ubiquitin–proteasome system Nature Reviews Drug Discovery. ,vol. 5, pp. 596- 613 ,(2006) , 10.1038/NRD2056
Mario Boccadoro, Gareth Morgan, Jamie Cavenagh, Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy. Cancer Cell International. ,vol. 5, pp. 18- 18 ,(2005) , 10.1186/1475-2867-5-18
Ismail Kola, John Landis, Can the pharmaceutical industry reduce attrition rates? Nature Reviews Drug Discovery. ,vol. 3, pp. 711- 716 ,(2004) , 10.1038/NRD1470
Gary K. Schwartz, Yuhong She, Francis Sirotnak, Carina Rizzo, Monica Motwani, Flavopiridol Enhances the Effect of Docetaxel in Vitro and in Vivo in Human Gastric Cancer Cells1 Molecular Cancer Therapeutics. ,vol. 2, pp. 549- 555 ,(2003)
Leigh Coultas, Andrew S. Kraft, Andrew S. Kraft, Thomas Johnson, Thomas Johnson, Jerry Adams, Hamsa Puthalalath, Malti Nikrad, The proteasome inhibitor bortezomib sensitizes cells to killing by death receptor ligand TRAIL via BH3-only proteins Bik and Bim Molecular Cancer Therapeutics. ,vol. 4, pp. 443- 449 ,(2005) , 10.1158/1535-7163.MCT-04-0260